Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Mancuso

Showing results (431-440 of 467) with videos related to

Pageof 47
Sort By:
Oncology Research|November 8, 2001
Growth inhibitory effects and radiosensitization induced by fatty aromatic acids on human cervical cancer cellsG Ferrandina, P Filippini, C Ferlini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2002
Increased cyclooxygenase-2 expression is associated with chemotherapy resistance and poor survival in cervical cancer patientsG Ferrandina, L Lauriola, M G Distefano, et al.
British Journal of Haematology|January 1, 1997
Generation of multinuclear tartrate-resistant acid phosphatase positive osteoclasts in liquid culture of purified human peripheral blood CD34+ progenitorsL Pierelli, G Scambia, G d'Onofrio, et al.
Anti-Cancer Drug Design|February 25, 1998
Antiproliferative activity of colchicine analogues on MDR-positive and MDR-negative human cancer cell linesR De Vincenzo, G Scambia, C Ferlini, et al.
Minerva Ginecologica|May 22, 1998
[Therapy of bacterial vaginosis. Prospective clinical study ot the efficacy and tolerability of quaternary ammonium salts vs. clindamycin]F Battaglia, G Scambia, R De Vincenzo, et al.
British Journal of Haematology|January 1, 1997
Purified unfractionated G-CSF/chemotherapy mobilized CD34+ peripheral blood progenitors and not bone marrow CD34+ progenitors undergo selective erythroid differentiation in liquid culture in the presence of erythropoietin and stem cell factorL Pierelli, G Scambia, G Menichella, et al.
The Journal of Nutrition|April 8, 2016
Relatively Low β-Cell Responsiveness Contributes to the Association of BMI with Circulating Glucose Concentrations Measured under Free-Living Conditions among Pregnant African American WomenPaula C Chandler-Laney, Desti N Shepard, Camille R Schneider, et al.
Experimental Hematology|March 25, 1999
Expansion of granulocyte colony-stimulating factor/chemotherapy-mobilized CD34+ hematopoietic progenitors: role of granulocyte-macrophage colony-stimulating factor/erythropoietin hybrid protein (MEN11303) and interleukin-15L Pierelli, G Scambia, G Bonanno, et al.
British Journal of Haematology|September 21, 2000
High cyclin-dependent kinase inhibitors in Bcl-2 and Bcl-xL-expressing CD34+-proliferating haematopoietic progenitorsM Marone, L Pierelli, S Mozzetti, et al.
Anticancer Research|June 9, 2001
Docetaxel and epirubicin plus G-CSF as mobilizing treatment to support high-dose chemotherapy in breast cancerL De Rosa, M Lalle, A Perillo, et al.
Pageof 47

Showing results (431-440 of 467) with videos related to

Sort By:
Pageof 47
Oncology Research|November 8, 2001
Growth inhibitory effects and radiosensitization induced by fatty aromatic acids on human cervical cancer cellsG Ferrandina, P Filippini, C Ferlini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2002
Increased cyclooxygenase-2 expression is associated with chemotherapy resistance and poor survival in cervical cancer patientsG Ferrandina, L Lauriola, M G Distefano, et al.
British Journal of Haematology|January 1, 1997
Generation of multinuclear tartrate-resistant acid phosphatase positive osteoclasts in liquid culture of purified human peripheral blood CD34+ progenitorsL Pierelli, G Scambia, G d'Onofrio, et al.
Anti-Cancer Drug Design|February 25, 1998
Antiproliferative activity of colchicine analogues on MDR-positive and MDR-negative human cancer cell linesR De Vincenzo, G Scambia, C Ferlini, et al.
Minerva Ginecologica|May 22, 1998
[Therapy of bacterial vaginosis. Prospective clinical study ot the efficacy and tolerability of quaternary ammonium salts vs. clindamycin]F Battaglia, G Scambia, R De Vincenzo, et al.
British Journal of Haematology|January 1, 1997
Purified unfractionated G-CSF/chemotherapy mobilized CD34+ peripheral blood progenitors and not bone marrow CD34+ progenitors undergo selective erythroid differentiation in liquid culture in the presence of erythropoietin and stem cell factorL Pierelli, G Scambia, G Menichella, et al.
The Journal of Nutrition|April 8, 2016
Relatively Low β-Cell Responsiveness Contributes to the Association of BMI with Circulating Glucose Concentrations Measured under Free-Living Conditions among Pregnant African American WomenPaula C Chandler-Laney, Desti N Shepard, Camille R Schneider, et al.
Experimental Hematology|March 25, 1999
Expansion of granulocyte colony-stimulating factor/chemotherapy-mobilized CD34+ hematopoietic progenitors: role of granulocyte-macrophage colony-stimulating factor/erythropoietin hybrid protein (MEN11303) and interleukin-15L Pierelli, G Scambia, G Bonanno, et al.
British Journal of Haematology|September 21, 2000
High cyclin-dependent kinase inhibitors in Bcl-2 and Bcl-xL-expressing CD34+-proliferating haematopoietic progenitorsM Marone, L Pierelli, S Mozzetti, et al.
Anticancer Research|June 9, 2001
Docetaxel and epirubicin plus G-CSF as mobilizing treatment to support high-dose chemotherapy in breast cancerL De Rosa, M Lalle, A Perillo, et al.
Pageof 47